Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zinmax
- Development stage
- Phase 2
- Lead developer
- EverWell
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Zinmax is a premium-grade dietary supplement ingredient developed by Nutrition21, consisting of a highly bioavailable zinc picolinate formulation. By combining zinc with picolinic acid, Zinmax offers enhanced absorption compared to other common forms of zinc such as zinc citrate or zinc gluconate. As an essential mineral supplement, it supports a wide range of physiological functions, including immune system health, cardiovascular function, cellular metabolism, and hormonal balance. It is designed for use in various delivery formats such as tablets, capsules, gummies, and functional foods, and is marketed as a branded ingredient for the dietary supplement industry rather than as a standalone pharmaceutical drug.
- Brand names
- Zinmax
- Other names
- zinc picolinate
Beyond the preview
Go deeper on Zinmax.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zinmax.